| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,994 |
3,046 |
$103K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
508 |
506 |
$24K |
| L3000 |
Foot, insert, removable, molded to patient model, 'ucb' type, berkeley shell, each |
58 |
29 |
$14K |
| 99243 |
|
133 |
132 |
$9K |
| 73630 |
|
351 |
242 |
$7K |
| 97035 |
|
336 |
143 |
$4K |
| 11721 |
|
135 |
135 |
$3K |
| A5500 |
For diabetics only, fitting (including follow-up), custom preparation and supply of off-the-shelf depth-inlay shoe manufactured to accommodate multi-density insert(s), per shoe |
64 |
33 |
$2K |
| A5512 |
For diabetics only, multiple density insert, direct formed, molded to foot after external heat source of 230 degrees fahrenheit or higher, total contact with patient's foot, including arch, base layer minimum of 1/4 inch material of shore a 35 durometer or 3/16 inch material of shore a 40 durometer (or higher), prefabricated, each |
46 |
32 |
$2K |
| 20550 |
|
36 |
30 |
$2K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
46 |
40 |
$909.83 |
| 29580 |
|
38 |
24 |
$818.17 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
46 |
41 |
$339.64 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
49 |
44 |
$272.19 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
617 |
458 |
$0.00 |